Literature DB >> 15177464

Synthesis of new 2'-beta-C-methyl related triciribine analogues as anti-HCV agents.

Kenneth L Smith1, Vicky C H Lai, Brett J Prigaro, Yili Ding, Esmir Gunic, Jean-Luc Girardet, Weidong Zhong, Zhi Hong, Stanley Lang, Haoyun An.   

Abstract

Ten new beta-D-ribofuranosyl and 2'-beta-C-methyl-beta-D-ribofuranosyl triciribine derivatives 4-13 with various N4 and 6-N substituents on the tricyclic ring were synthesized from the corresponding toyocamycin and new 2'-beta-C-methyl toyocamycin derivatives. The inhibitory studies of these compounds in the HCV replicon assay reveal that some of them possess interesting anti-HCV properties with low cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177464     DOI: 10.1016/j.bmcl.2004.04.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Preparation of ribavirin analogues by copper- and ruthenium-catalyzed azide-alkyne 1,3-dipolar cycloaddition.

Authors:  Ugo Pradere; Vincent Roy; Tamara R McBrayer; Raymond F Schinazi; Luigi A Agrofoglio
Journal:  Tetrahedron       Date:  2008-07-05       Impact factor: 2.457

Review 2.  Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.

Authors:  Pavla Perlíková; Michal Hocek
Journal:  Med Res Rev       Date:  2017-08-23       Impact factor: 12.944

3.  Versatile synthesis and biological evaluation of novel 3'-fluorinated purine nucleosides.

Authors:  Hang Ren; Haoyun An; Paul J Hatala; William C Stevens; Jingchao Tao; Baicheng He
Journal:  Beilstein J Org Chem       Date:  2015-12-09       Impact factor: 2.883

4.  Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as anti-hyperglycemic agents.

Authors:  M S Mohamed; S A Ali; D H A Abdelaziz; Samar S Fathallah
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

5.  5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents.

Authors:  Masahiro Ikejiri; Takayuki Ohshima; Keizo Kato; Masaaki Toyama; Takayuki Murata; Kunitada Shimotohno; Tokumi Maruyama
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.